In This Section
Case Study
Find out how inVentiv helps a large pharma company regain lost ground for a product that has been on the market for three years.
Management Team
Mike Hlinak leads inVentiv Clinical's management team, a team composed of best-of-class industry professionals with the skills and experience to lead the organization to each of its goals and objectives.
Michael Hlinak
President and Chief Executive Officer
inVentiv Clinical
Michael Hlinak has more than 20 years of financial and operations management experience in both publicly and privately owned organizations, including staffing, telecommunications, real estate development, and management, retail, and medical. As President and CEO of inVentiv Clinical Solutions, he leads the clinical development outsourced services business (inVentiv Clinical Solutions) as well as the clinical staffing groups (MedFocus and Smith Hanley Consulting Group).
Mr. Hlinak took the reins of inVentiv Clinical Solutions after inVentiv Health's acquisition of Smith Hanley, an industry leading permanent executive placement and contract staffing firm. At Smith Hanley, he held the position of CFO, overseeing all financial aspects of the business and responsible for pursuing corporate development opportunities. Before Smith Hanley, Mr. Hlinak held senior financial positions at Work International Corporation, Equal Net and Cardinal Interests.
Mr. Hlinak received a B.S. in Business Administration from Lamar University in Beaumont, Texas, and completed MBA coursework at the University of Houston. He is also a Certified Public Accountant in the state of Texas.
Scott Treiber, PhD, MBA
Executive Vice President,
Clinical Development Solutions
inVentiv Clinical Solutions
Dr. Scott Treiber has more than 20 years experience in the clinical and medical research industries with a strong background in contract research organizations. He is currently responsible for the oversight of all aspects of clinical monitoring and project management at inVentiv Clinical Solutions, including executive project oversight and client interaction.
Prior to joining inVentiv, Dr. Treiber held positions of increasing responsibility in reputed contract clinical research organizations such as Quintiles, ICON and Premier Research. Most recently, he was Vice President of Clinical Research for PharmaNet, with overall responsibility for the Neuroscience, Cardiovascular/General Medicine, Ophthalmology and Dermatology therapeutic divisions.
Dr. Treiber received his PhD in Biology from the University of California at Santa Cruz and his MBA from Ellis College of the New York Institute of Technology. He received his undergraduate degree in Biology from the University of Iowa. Dr. Treiber is also published in a number of journals for his research on sleep disorders.
Gerald M. Kappes, CPA
Chief Financial Officer
inVentiv Clinical Solutions
Gerald Kappes brings more than 15 years of experience in accounting and finance to inVentiv Clinical Solutions. He is responsible for all aspects of accounting and financial management for the company.
Prior to joining inVentiv Clinical, Mr. Kappes was a Sr. Accountant at Reliant Energy, Inc., a publicly traded energy company, where he was responsible for handling all financial reporting matters. Previously, he was Controller for WorldByNet.com, a start-up Internet company, where he was responsible for developing the accounting team and all accounting processes, including the accounting system conversion and the implementation of an e-commerce platform. Mr. Kappes was also the Controller for EqualNet Communications Corporation, a publicly traded telecommunications company.
Mr. Kappes received his B.S. in Accounting from the University of Texas at Austin and is a licensed CPA in the state of Texas.
Christopher L. Crucitti
Senior Vice President, Business Development
inVentiv Clinical Solutions
Christopher L. Crucitti brings over 10 years experience in the clinical research business. He is responsible for leading global sales, marketing and business development efforts to drive revenue growth for the company. His skills and responsibilities have spanned operations/project management, global sales team management, corporate marketing, global proposal development and budgeting, client contracts and training. He has extensive experience in a wide range of market segments to include imaging, resourcing, consulting and clinical drug development services.
Prior to joining inVentiv Clinical Solutions, Mr. Crucitti supported business development for i3 Research, with escalating levels of responsibility, ultimately leading a North America team. Prior to that, he was responsible for business development at Medifacts International, a cardiovascular-focused CRO and core laboratory.
Mr. Crucitti holds a B.S. in Exercise Science and Cardiac Rehabilitation from Ithaca College and an M.S. in Health Management from American University.
Jeffery Fetterman
President
ParagonRx
Jeff Fetterman is President of ParagonRx a company serving pharmaceutical, biotech, and medical device industries by designing, implementing, and continuously improving programs that guide appropriate use of medications and medical products. As co-author of two pharmaceutical risk management books and consultant for numerous risk management programs, he is helping to pioneer this emerging field in our industry. Having led the pre-startup safety assessment of the only nuclear reactor to be renovated following deactivation, Mr. Fetterman is familiar with the cross-industry implications of risk management techniques.
In previous work, he co-founded Empower Health, a business that integrated tools and services to improve clinical health outcomes of people with chronic illness. Mr. Fetterman has extensive pharmaceutical industry experience, having led marketing, medical education, strategic planning, and business development organizations at DuPont Pharmaceuticals and DuPont Consumer Health.
Mr. Fetterman holds a B.S. in Chemical Engineering from LeHigh University and a M.B.A. from the Katz School of Business at the University of Pittsburgh.
Thomas A. Hanley, Jr.
Chief Executive Officer
Smith Hanley Holding Company
Thomas Hanley leads the permanent placement business, Smith Hanley Associates, within the inVentiv Clinical division of inVentiv Health.
Prior to his current role, Mr. Hanley was President and CEO of the Smith Hanley Companies, which was acquired by inVentiv Health in October 2004. He co-founded Smith Hanley Associates, Inc., in 1980, developed the firm's Consulting Group in 1995, and acquired MedFocus in 2000. The client base for these firms includes the top pharmaceutical and biotechnology firms in the United States.
Mr. Hanley received a B.S. in Biology from Rensselaer Polytechnic Institute, and completed the course work for an M.S. degree in Environmental Engineering at Rensselaer Polytechnic Institute. Concurrent with the creation of Smith Hanley, he attended New York Law School, graduating cum laude with his J.D. degree.
